SCHEMBL21783387

SCHEMBL21783387

Cc1cc(SN(C(=O)OC(C)(C)C)c2ccsn2)ncc1F

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783527 0.81
SCHEMBL21783386 0.77 SCN8A (0.33) SSTR4
SCHEMBL30845678 0.77 SCN8A (0.33) SSTR4
SCHEMBL21783536 0.70 SCN8A (0.33)
SCHEMBL21783459 0.69 SCN8A (0.32)
SCHEMBL16638904 0.69 SYK (0.36) SSTR4
SCHEMBL28335538 0.69 PAX8 (0.32) SSTR4
SCHEMBL21783403 0.68 QPCT (0.32)
SCHEMBL19631663 0.67 SCN8A (0.32) SSTR4
SCHEMBL22331230 0.65 SCN8A (0.35) SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047312-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed
WO-2020047323-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed